vs

Side-by-side financial comparison of BLACKLINE, INC. (BL) and HUTCHMED (China) Ltd (HCM). Click either name above to swap in a different company.

HUTCHMED (China) Ltd is the larger business by last-quarter revenue ($270.8M vs $183.2M, roughly 1.5× BLACKLINE, INC.). BLACKLINE, INC. runs the higher net margin — 2.7% vs 0.7%, a 1.9% gap on every dollar of revenue. On growth, BLACKLINE, INC. posted the faster year-over-year revenue change (8.1% vs -16.5%). BLACKLINE, INC. produced more free cash flow last quarter ($26.1M vs $3.4M).

BlackLine Systems, Inc., is an American enterprise software company that develops cloud-based services designed to automate and manage the entire financial close process as well as consolidation, invoice-to-cash, and intercompany accounting. The Los Angeles–based company has 17 offices worldwide.

HUTCHMED (China) Ltd is a biopharmaceutical firm focused on discovering, developing and commercializing targeted and immunotherapies for oncology and immunological diseases. It operates across China and global markets, with multiple marketed oncology drugs and a robust pipeline of late-stage clinical candidates addressing unmet patient needs.

BL vs HCM — Head-to-Head

Bigger by revenue
HCM
HCM
1.5× larger
HCM
$270.8M
$183.2M
BL
Growing faster (revenue YoY)
BL
BL
+24.6% gap
BL
8.1%
-16.5%
HCM
Higher net margin
BL
BL
1.9% more per $
BL
2.7%
0.7%
HCM
More free cash flow
BL
BL
$22.7M more FCF
BL
$26.1M
$3.4M
HCM

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
BL
BL
HCM
HCM
Revenue
$183.2M
$270.8M
Net Profit
$4.9M
$2.0M
Gross Margin
75.2%
37.7%
Operating Margin
3.7%
-13.2%
Net Margin
2.7%
0.7%
Revenue YoY
8.1%
-16.5%
Net Profit YoY
-91.3%
-83.6%
EPS (diluted)
$0.07
$0.00

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
BL
BL
HCM
HCM
Q4 25
$183.2M
$270.8M
Q3 25
$178.3M
Q2 25
$172.0M
$277.7M
Q1 25
$166.9M
$324.5M
Q4 24
$169.5M
Q3 24
$165.9M
Q2 24
$160.5M
$305.7M
Q1 24
$157.5M
Net Profit
BL
BL
HCM
HCM
Q4 25
$4.9M
$2.0M
Q3 25
$5.3M
Q2 25
$8.3M
$455.0M
Q1 25
$6.1M
$11.9M
Q4 24
$56.4M
Q3 24
$17.2M
Q2 24
$76.7M
$25.8M
Q1 24
$10.8M
Gross Margin
BL
BL
HCM
HCM
Q4 25
75.2%
37.7%
Q3 25
75.1%
Q2 25
75.2%
0.1%
Q1 25
75.5%
48.0%
Q4 24
75.6%
Q3 24
75.2%
Q2 24
74.9%
41.1%
Q1 24
75.2%
Operating Margin
BL
BL
HCM
HCM
Q4 25
3.7%
-13.2%
Q3 25
4.3%
Q2 25
4.4%
-1.3%
Q1 25
2.1%
-5.0%
Q4 24
3.7%
Q3 24
5.0%
Q2 24
1.4%
-9.0%
Q1 24
1.1%
Net Margin
BL
BL
HCM
HCM
Q4 25
2.7%
0.7%
Q3 25
3.0%
Q2 25
4.8%
163.8%
Q1 25
3.6%
3.7%
Q4 24
33.3%
Q3 24
10.4%
Q2 24
47.8%
8.4%
Q1 24
6.9%
EPS (diluted)
BL
BL
HCM
HCM
Q4 25
$0.07
$0.00
Q3 25
$0.09
Q2 25
$0.13
$0.52
Q1 25
$0.10
$0.01
Q4 24
$0.79
Q3 24
$0.27
Q2 24
$0.22
$0.03
Q1 24
$0.17

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
BL
BL
HCM
HCM
Cash + ST InvestmentsLiquidity on hand
$390.0M
$1.4B
Total DebtLower is stronger
$93.2M
Stockholders' EquityBook value
$332.3M
$1.2B
Total Assets
$1.8B
$1.8B
Debt / EquityLower = less leverage
0.08×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
BL
BL
HCM
HCM
Q4 25
$390.0M
$1.4B
Q3 25
$419.9M
Q2 25
$459.1M
$1.4B
Q1 25
$479.5M
$836.1M
Q4 24
$885.9M
Q3 24
$725.3M
Q2 24
$616.6M
$802.5M
Q1 24
$331.4M
Total Debt
BL
BL
HCM
HCM
Q4 25
$93.2M
Q3 25
Q2 25
$93.4M
Q1 25
$82.8M
Q4 24
Q3 24
Q2 24
$82.1M
Q1 24
Stockholders' Equity
BL
BL
HCM
HCM
Q4 25
$332.3M
$1.2B
Q3 25
$328.3M
Q2 25
$414.0M
$1.2B
Q1 25
$417.9M
$759.9M
Q4 24
$446.7M
Q3 24
$367.9M
Q2 24
$325.8M
$740.1M
Q1 24
$279.8M
Total Assets
BL
BL
HCM
HCM
Q4 25
$1.8B
$1.8B
Q3 25
$1.7B
Q2 25
$1.8B
$1.8B
Q1 25
$1.8B
$1.3B
Q4 24
$1.8B
Q3 24
$1.7B
Q2 24
$1.9B
$1.3B
Q1 24
$2.1B
Debt / Equity
BL
BL
HCM
HCM
Q4 25
0.08×
Q3 25
Q2 25
0.08×
Q1 25
0.11×
Q4 24
Q3 24
Q2 24
0.11×
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
BL
BL
HCM
HCM
Operating Cash FlowLast quarter
$26.7M
$8.2M
Free Cash FlowOCF − Capex
$26.1M
$3.4M
FCF MarginFCF / Revenue
14.2%
1.2%
Capex IntensityCapex / Revenue
0.3%
1.8%
Cash ConversionOCF / Net Profit
5.46×
4.21×
TTM Free Cash FlowTrailing 4 quarters
$161.5M
$-96.2M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
BL
BL
HCM
HCM
Q4 25
$26.7M
$8.2M
Q3 25
$63.8M
Q2 25
$32.3M
$-72.9M
Q1 25
$46.7M
$40.3M
Q4 24
$43.8M
Q3 24
$55.9M
Q2 24
$40.7M
$-39.8M
Q1 24
$50.4M
Free Cash Flow
BL
BL
HCM
HCM
Q4 25
$26.1M
$3.4M
Q3 25
$63.3M
Q2 25
$31.4M
$-82.2M
Q1 25
$40.8M
$32.5M
Q4 24
$43.0M
Q3 24
$55.5M
Q2 24
$40.0M
$-49.9M
Q1 24
$50.1M
FCF Margin
BL
BL
HCM
HCM
Q4 25
14.2%
1.2%
Q3 25
35.5%
Q2 25
18.2%
-29.6%
Q1 25
24.4%
10.0%
Q4 24
25.4%
Q3 24
33.5%
Q2 24
24.9%
-16.3%
Q1 24
31.8%
Capex Intensity
BL
BL
HCM
HCM
Q4 25
0.3%
1.8%
Q3 25
0.3%
Q2 25
0.6%
3.3%
Q1 25
3.6%
2.4%
Q4 24
0.4%
Q3 24
0.2%
Q2 24
0.4%
3.3%
Q1 24
0.2%
Cash Conversion
BL
BL
HCM
HCM
Q4 25
5.46×
4.21×
Q3 25
12.07×
Q2 25
3.90×
-0.16×
Q1 25
7.72×
3.38×
Q4 24
0.78×
Q3 24
3.24×
Q2 24
0.53×
-1.54×
Q1 24
4.66×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

BL
BL

Subscription And Circulation$173.2M95%
Technology Service$10.0M5%

HCM
HCM

Segment breakdown not available.

Related Comparisons